Editorial: Gene therapy for the central and peripheral nervous system, volume II

Andrew P Tosolini; George M Smith

doi:10.3389/fnmol.2023.1258458

Editorial: Gene therapy for the central and peripheral nervous system, volume II

Front Mol Neurosci. 2023 Aug 1:16:1258458. doi: 10.3389/fnmol.2023.1258458. eCollection 2023.

Authors

Andrew P Tosolini^{1

2

3

4}, George M Smith^{5

6}

Affiliations

¹ Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, United Kingdom.
² UCL Queen Square Motor Neuron Disease Centre, University College London, London, United Kingdom.
³ Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, QLD, Australia.
⁴ School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia.
⁵ Shriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
⁶ Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.

No abstract available

Keywords: AAV; CNS; PNS; circRNAs; gene therapy; lncRNA; miRNA; transduction.

Publication types

Editorial

Grants and funding

This work has been supported by a Junior Non-Clinical Fellowship from the Motor Neuron Disease Association (Tosolini/Oct20/973-799) (AT), a FightMND Grant awarded to Giovanni Nardo (Istituto di Ricerche Farmacologiche Mario Negri IRCCS) (DDG-73) (AT), and a NIH NINDS grant (R01NS117749-01) (GS).